Genomind 360
Learning Center

Healthcare providers

Psychiatric Case Roundtable

Genomind Educational Webinar event card with Judith C. Engelman, MD, Jennifer Reed, PMHNP-BC, Rachel Schmuts, DO, PMH-C

Join Genomind and our panel of experts for a psychiatric case roundtable with a focus on pharmacogenetics. Our panel features Dr. Judith Engelman, MD, Jennifer Reed, PMHNP-BC, and Dr. Rachel Shmuts, DO, PMH-C, and is moderated by members of Genomind’s Medical Affairs team, Dr. Seema Patel, PharmD, BCPP and Dr. Gabriela Williams, PharmD, BCPS, BCPP.

  • Dr. Judith Engelman has been a board certified psychiatrist for 38 years. She currently is a faculty member at Mayo Clinic Alix School of Medicine and Science, and works with Mayo Clinic practitioners and medical students in the areas of wellness and resilience.
  • Jennifer Reed, PMHNP-BC is board certified in both family practice and psychiatric mental health. She has a diverse medical experience in several specialties, including cardiology, oncology, and intensive care.
  • Dr. Rachel Shmuts is the inaugural Vice Chair of Education and an Associate Clinical Professor of the Department of Psychiatry at Rowan University School of Osteopathic Medicine. She also consults on the use of transcranial magnetic stimulation and is certified as a perinatal mental healthcare provider.

In this hour-long discussion, each of our experienced clinicians share an anonymous psychiatric case and review the pharmacogenetic insights they found to be beneficial in making treatment decisions.

Filmed June 24th, 2021

Are You Ready to Upgrade Your Practice with Genomind?

Get smarter mental health prescribing guidance that’s good for life. Genomind® Professional PGx Express™ is the most advanced and comprehensive mental health pharmacogenetic test available. Get access to 24 genes related to mental health, 130+ medications, 10+ conditions, state-of-the-art tools, and 360 degrees of support today!

Continued education to evolve your practice.

Free educational content and resources direct from the Genomind team.

This field is for validation purposes and should be left unchanged.